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Enzymatic activity by ammonia Nessler assay, primary identification by LC-MS
methods and secondary structure characterization by FTIR techniques have
been shown in these preliminary experiments to be suitable stability-indicating
quality attributes and methods, which will be further developed.
Drug Quality & Registration (DruQuaR) format Man06.001.006-v01
Develop Nessler method for enzyme activity of ASNASE.
Characterization of primary and secondary structure of ASNASE.
DruQuaR
2.Structure characterization
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Asparaginase (ASNASE) catalyzes the deamidation of asparagine and is
therapeutically used for acute lymphoblastic leukemia (ALL)[1]. In order to
extend its clinical development, a functional-rationalized quality monograph for
ASNASE need to be established which can serve as a basis for generic
ASNASE pharmacopeial purposes or in product development and stability
studies. The quality attributes should also include the intrinsic stability and
excipient compatibility, which are the current hurdles in the clinical applications.
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2.1 Primary structure: LC-MS methods, e.g. whole protein mass analysis
2.3 Secondary structure: FTIR
Fig 2. The effects of the four variables and their interactions for the 
absorbance of Nessler assay following D-optimal onion experimental design 
Nessler assay 
Four variables: CKI/CHgI2, CNaOH/CHgI2, CHgI2 final and reaction time
Design of Experiment (DoE): D-optimal onion design (DOOD); The
significance of the variables and their interactions for the response
(absorbance at 425 nm) are shown at Figure 2.
Optimal ranges of four variables:
•CKI/CHgI2 [1.9-1.95]
•CNaOH/CHgI2 [17.0-18.0]
•CHgI2 final (mM) [27.0-35.0]
•Time (min) [10.0-13.0]
Fig 1. The mechanism of ASNASE activity and Nessler's reaction Secondary structure content (K2D, K2D2 and Raussens): 29.26%
α-helix and 19.68% β-sheet (mean content).
The melting temperature (Tm) : Temperature range of 60-63℃ :
denaturation of β-sheet; 63-65℃: denaturation of α-helix (Fig 4.).
Fig 3. The mass spectrum of E. coli ASNASE
Fig 5. Typical part of FTIR spectra of E. coli ASNASE: amide I and II bands 
(native ASNASE (blue) and heat-stressed ASNASE (red)
Fig 4. Temperature-stability CD spectra of E. coli ASNASE
2.2 Secondary structure: Circular dichroism (CD)
Calculated MW of E. coli ASNASE : 34590 ± 2 (Fig. 3).
Amide I and II infrared bands allow stability-indicating secondary structure
estimation.
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